Bristol Myers Squibb (NYSE: BMY) reported its fourth quarter 2025 earnings results today.
Revenues increased 1% year-over-year to $12.5 billion.
GAAP net income attributable to Bristol Myers Squibb was $1.1 billion, or $0.53 per share, versus $72 million, or $0.04 per share, last year. Adjusted EPS decreased 25% to $1.26.
US revenues were $8.6 billion while international revenues were $3.9 billion.
For fiscal year 2026, the company expects total revenues to be $46.0-47.5 billion and adjusted EPS to be $6.05-6.35.